You have 9 free searches left this month | for more free features.

Skin and soft tissue infections

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Scalp Dermatitis Trial in Hanoi (TD03, TD07, Ketoconazole 2% Shampoo)

Recruiting
  • Scalp Dermatitis
  • TD03
  • +2 more
  • Hanoi, Vietnam
    Nationa Hospital of Dermatology
Sep 13, 2021

Musculoskeletal Pain Trial in Frederiksberg (Physiotherapeutic treatment and medical care, medical care)

Recruiting
  • Musculoskeletal Pain
  • Physiotherapeutic treatment and medical care
  • medical care
  • Frederiksberg, Denmark
    Parker Instituttet, Frederiksberg Hospital
Oct 7, 2022

KRAS NP_004976.2:p.G12R, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7 Trial in United

Completed
  • KRAS NP_004976.2:p.G12R
  • +2 more
  • Laboratory Biomarker Analysis
  • Selumetinib Sulfate
  • Los Angeles, California
  • +8 more
Jan 20, 2021

Iliofemoral Venous Obstruction Trial in Worldwide (Abre venous self-expanding stent system)

Completed
  • Iliofemoral Venous Obstruction
  • Abre venous self-expanding stent system
  • Orange, California
  • +23 more
Oct 17, 2022

The Role of Incretins in Bone Remodeling in Humans

Recruiting
  • Incretins
  • +3 more
  • blood sample
  • Angers, France
    CHU Angers
Jul 27, 2022

Obesity, Childhood Trial (Monthly bolus of cholecalciferol per os, Daily dose of cholecalciferol per os, Control)

Not yet recruiting
  • Obesity, Childhood
  • Monthly bolus of cholecalciferol per os
  • +2 more
  • (no location specified)
Nov 16, 2022

Biliary Carcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Trial in Tampa (Cisplatin, Gemcitabine, Copanlisib)

Completed
  • Biliary Carcinoma
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 3, 2021

Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab)

Completed
  • Esophageal Carcinoma
  • Esophagogastric Junction Carcinoma
  • pembrolizumab
  • (no location specified)
Aug 18, 2022

Neurosciences Research Repository

Recruiting
  • Neurological Conditions
  • tissue and data repository
  • Houston, Texas
    Memorial Hermann Hospital
Sep 9, 2022

Tumour Regulatory Molecules in Early Pancreatic Cancer Detection

Recruiting
  • Cancer of Pancreas
  • Pancreas Cyst
    • Cottingham, Kingston Upon Hull, United Kingdom
      Castle Hill Hospital, Hull University Teaching Hospitals NHS Tru
    Jul 12, 2022

    Non-Immune Hydrops Fetalis Trial in France (NON-IMMUNE HYDROPS FETALIS diagnosis)

    Recruiting
    • Non-Immune Hydrops Fetalis
    • NON-IMMUNE HYDROPS FETALIS diagnosis
    • Besançon, France
    • +16 more
    Jan 17, 2022

    Positron-Emission Tomography Trial in Fuzhou (68Ga-Pentixafor)

    Recruiting
    • Positron-Emission Tomography
    • 68Ga-Pentixafor
    • Fuzhou, Fujian, China
      Department of Nuclear Medicine, First Affiliated Hospital of Fuj
    Jul 27, 2022

    Epidemiology Non-cholera Vibrio Infections

    Completed
    • Vibrio Infections
    • non-cholera Vibrio infection
    • Angers, France
    • +6 more
    Mar 15, 2021

    Esophageal Achalasia Trial in Nantes (Esophageal biopsies during Peroral Endoscopic Myotomy (POEM))

    Recruiting
    • Esophageal Achalasia
    • Esophageal biopsies during Peroral Endoscopic Myotomy (POEM)
    • Nantes, France
      Nantes UH
    Dec 31, 2021

    Prostate Cancer Trial in Hong Kong (Hemopatch)

    Completed
    • Prostate Cancer
    • Hemopatch
    • Hong Kong, Hong Kong
      Prince of Wales Hospital
    Jun 24, 2022

    Hepatocellular Carcinoma Trial in Worldwide (Sorafenib)

    Completed
    • Hepatocellular Carcinoma
    • Tucson, Arizona
    • +23 more
    Apr 16, 2021

    Diabetes, Type 2 Trial in Czechia, Thailand (Insulin Icodec, Semaglutide)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Broumov, Czechia
    • +7 more
    Apr 3, 2023

    Cancer Trial in Shenzhen (No experimental interventions 1. Observation; 2. Anticancer treatments, including surgery, systemic

    Recruiting
    • Cancer
    • No experimental interventions 1. Observation; 2. Anticancer treatments, including surgery, systemic therapy, radiotherapy, Chinese traditional medicine, or palliative/supportive care.
    • Shenzhen, Guangdong, China
      UHongKongShenzhen
    Sep 20, 2021

    Bone Loss, Implant Site Injury Trial in Mola di Bari (bone and soft tissue augmentation)

    Recruiting
    • Bone Loss
    • Implant Site Injury
    • bone and soft tissue augmentation
    • Mola di Bari, Bari, Italy
      Giuseppe D'Albis
    Jul 25, 2022

    Type 1 Diabetes Trial in Canada, United States (GAD-Alum, GAD-Alum and Aluminum hydroxide, Aluminum hydroxide)

    Completed
    • Type 1 Diabetes Mellitus
    • Los Angeles, California
    • +14 more
    Apr 27, 2020

    Clostridium Difficile Trial in United States (Universal gloving)

    Recruiting
    • Clostridium Difficile
    • Universal gloving
    • Washington, District of Columbia
    • +5 more
    Mar 31, 2022

    Metabolic Diseases Trial in London (Period 1 Visit 1 - Cold PET-CT Vehicle, Visit 2 -Warm PET-CT Vehicle, Period 1 Visit 1 -

    Completed
    • Metabolic Diseases
    • Period 1 Visit 1 - Cold PET-CT Vehicle, Visit 2 -Warm PET-CT Vehicle
    • +8 more
    • London, United Kingdom
      Imperial College London
    May 17, 2021

    Diabetes, Type 1 Trial in Worldwide (insulin icodec, insulin degludec, insulin aspart)

    Completed
    • Diabetes Mellitus, Type 1
    • insulin icodec
    • +2 more
    • Concord, California
    • +98 more
    Feb 2, 2023

    Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases

    Not yet recruiting
    • Multi-Drug Resistant Hiv-1 Infection
    • HIV-1 Infection
    • UB-421
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Gonadotropin-releasing Hormone Agonist in Ovarian Preservation

    Recruiting
    • Systemic Lupus Erythematosus (Sle)
    • Primary Ovarian Insufficiency (Poi)
      • Bethesda, Maryland
        National Institute of Arthritis and Musculoskeletal and Skin Dis
      Feb 2, 2023